dexamethasone phosphate

The medicine is used to treat eye inflammation. It contains a substance that inhibits inflammatory symptoms.

Form: drops, ophthalmic solution

ATC: S01BA01

Manufacturer: Laboratoires THEA

The medicine is used to treat ocular inflammation. It works by inhibiting the symptoms of inflammation.

Form: drops, ophthalmic solution

ATC: S01BA01

Manufacturer: Laboratoires THEA

The medicine is intended for the treatment of ocular inflammation. It inhibits the symptoms of inflammation.

Form: drops, ophthalmic solution

ATC: S01BA01

Manufacturer: Laboratoires Thea

The medicine is used to treat many conditions that require the administration of glucocorticosteroids. It may be used, among others, for cerebral edema, post-traumatic shock, severe asthma attacks, COVID-19 (in adults and adolescents with breathing difficulties), rheumatic diseases, severe skin diseases, and to alleviate symptoms of cancer.

Form: solution for injection for infusion

ATC: H02AB02

Manufacturer: Accord Healthcare Polska Ltd. Laboratori Fundació Dau Pharmadox Healthcare Ltd.

The medicine is used in emergencies, such as cerebral edema, anaphylactic shock, severe asthma attacks, certain skin diseases, and severe blood disorders. It is also used in the treatment of COVID-19 in adults and adolescents (12+ years, min. 40 kg) with breathing difficulties requiring oxygen therapy. It can be administered systemically or locally, e.g., near joints.

Form: solution for injection and infusion

ATC: H02AB02

Manufacturer: AS Kalceks

The medicinal product is used in the treatment of many diseases requiring glucocorticosteroids. It may be administered systemically (e.g., in cerebral edema, severe asthma attacks, rheumatic diseases, COVID-19 in adults and adolescents with breathing difficulties, or as supportive treatment in cancer) or locally (e.g., in inflammation of joints, tendons, or the eye).

Form: solution for injection for infusion

ATC: H02AB02

Manufacturer: Krka, d.d., Novo mesto

The medicinal product is used in the treatment of many conditions requiring glucocorticosteroids. It may be administered systemically (e.g., in cerebral edema, severe asthma attacks, COVID-19, rheumatic diseases, or cancer) as well as locally (e.g., in inflammation of joints, tendons, or the eye).

Form: solution for injection for infusion

ATC: H02AB02

Manufacturer: Krka, d.d., Novo mesto